Filing Details
- Accession Number:
- 0001127602-10-010296
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-02 13:00:00
- Reporting Period:
- 2010-04-01
- Filing Date:
- 2010-04-02
- Accepted Time:
- 2010-04-02 16:27:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1370940 | Maxim John Ferrari | 1110 Spring Street Silver Spring MD 20910 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-01 | 3,330 | $26.86 | 3,330 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-01 | 3,330 | $55.13 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-04-01 | 3,763 | $27.97 | 3,763 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-01 | 3,763 | $55.13 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2010-04-01 | 3,330 | $0.00 | 3,330 | $26.86 |
Common Stock | Stock Options | Disposition | 2010-04-01 | 3,763 | $0.00 | 3,763 | $27.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-08-10 | 2016-08-10 | No | 4 | M | Direct |
14,237 | 2008-03-15 | 2017-03-15 | No | 4 | M | Direct |
Footnotes
- This exercise of stock options and corresponding sale of shares is pursuant to the 10b5-1 Plan adopted by the reporting person on August 7, 2009.